Bentham Science Logo

Track Your Manuscript:


Current Drug Targets

Volume 21, 16 Issues, 2020
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Drug Targets, Volume 17 - Number 2




The Role of JNK Signalling in Responses to Oxidative DNA Damage

, 17(2): 154 - 163

Zeeshan Shaukat, Dawei Liu, Rashid Hussain, Mahwish Khan and Stephen L. Gregory


DOI: 10.2174/1389450116666150126111055



Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance

, 17(2): 164 - 177

Gabriela Nestal de Moraes, Laura Bella, Stefania Zona, Matthew J. Burton and Eric W.-F. Lam


DOI: 10.2174/1389450115666141122211549





Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions

, 17(2): 206 - 228

Rakesh Raj, Pooja Mongia, Suresh Kumar Sahu and Alpana Ram


DOI: 10.2174/1389450116666150722141607



The Use of Mesenchymal Stem Cells for the Treatment of Autoimmunity: From Animals Models to Human Disease

, 17(2): 229 - 238

Alessandra Fierabracci, Andrea Del Fattore, Marta Muraca, Domenico Vittorio Delfino and Maurizio Muraca


DOI: 10.2174/1389450116666150722140633





Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)

View Full Editorial Board

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.63

Advertisement

STATISTICS AND DATA PRESENTATIONCovid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog